#406 ‒ Migraine, cluster headache, and tension headache: symptoms, causes, prevention, and treatment | Brian Grosberg, M.D.

Aug 31, 2026 Episode Page ↗
Overview

Dr. Brian Grosberg, a world-renowned headache specialist, provides a master class on headache disorders. He distinguishes primary from secondary headaches, detailing migraine, cluster, and tension headaches, their pathophysiology, and the latest treatments including CGRP antagonists and neuromodulation devices. He emphasizes individualized care and lifestyle interventions.

At a Glance
13 Insights
1h 55m Duration
26 Topics
10 Concepts

Deep Dive Analysis

Introduction to Headache Specialization

Challenges in Headache Diagnosis

Primary vs. Secondary Headaches Explained

Tension-Type Headache Characteristics

Migraine Diagnostic Criteria and Symptoms

Allodynia and Migraine Treatment Timing

Phases of a Migraine Attack

Migraine Prevalence and Societal Burden

Chronic Migraine and Specialist Shortage

Genetic and Hormonal Factors in Migraine

Migraine Triggers and Headache Diaries

Menopausal Migraine and Hormone Replacement

Cluster Headache: Symptoms and Misdiagnosis

Lifestyle Interventions for Headache Prevention

Goals and Indications for Preventive Headache Therapy

Pharmacological Prevention: Beta Blockers and Antidepressants

Pharmacological Prevention: Anti-Epileptic Drugs

Pathophysiology of Migraine and CGRP Antagonists

CGRP Antagonists: Monoclonal Antibodies and Gepants

Calcium Channel Blockers and Botox for Headache Prevention

Acute Treatment of Migraine: Non-Specific vs. Specific

Triptans for Acute Migraine Treatment

Neuromodulation Devices for Headache

Cannabinoids for Headache Treatment

Hope and Patient Empowerment in Headache Management

Warning Signs for Secondary Headaches

Primary Headaches

Headaches that are a condition in themselves, not caused by another underlying medical issue. Examples include migraine, tension-type headache, and cluster headache, which are diagnosed based on specific criteria rather than biomarkers.

Secondary Headaches

Headaches that are symptoms of another underlying condition, which can range from life-threatening issues like brain tumors or aneurysms to non-life-threatening causes like medication overuse or caffeine withdrawal.

Allodynia

An uncomfortable sensation to things that normally are not uncomfortable, such as pulling hair back or wearing glasses. This phenomenon is present in about two-thirds of migraine sufferers and indicates central sensitization, making acute treatments like triptans less effective if delayed.

Migraine Phases

Migraine is not just a headache but a sequence of phases: premonitory (calm before the storm), aura (reversible neurological symptoms), headache (pain and associated symptoms), and postdrome (hangover-like feeling after pain subsides).

Cortical Spreading Depolarization

A wave of excitability followed by relaxation that starts in the visual cortex at the back of the brain and spreads across nerve cells. This phenomenon is the underlying mechanism for migraine aura, causing visual or other neurological disturbances.

Interictal Burden

The impact of migraine on a person's life between headache attacks, characterized by anticipatory anxiety about when the next migraine will strike and how it affects daily planning and activities.

Medication Overuse Headache

An increase in headache frequency caused by the regular overuse of acute pain medications, including NSAIDs, simple analgesics, triptans, opioids, and barbiturate-containing combination analgesics. This risk factor can lead to chronic headache.

Neurovascular Phenomenon

The current understanding of migraine pathophysiology, recognizing that it involves both the nervous system and cranial blood vessels. This model is more complex than the older, purely vascular hypothesis of migraine.

CGRP (Calcitonin Gene-Related Peptide)

A chemical messenger or neuropeptide heavily involved in migraine pathophysiology. Elevated levels are found during migraine attacks, and targeting CGRP or its receptors has led to a new class of effective migraine treatments called CGRP antagonists.

Neuromodulation Devices

External devices that deliver magnetic or electrical stimulation to specific nerves or areas of the nervous system to suppress pain transmission or down-regulate pain. These are used for both acute treatment and prevention of headaches, including migraine.

?
What is the primary difference between primary and secondary headaches?

Primary headaches are a condition in themselves (e.g., migraine), not caused by another issue, while secondary headaches are symptoms of an underlying condition, which can be life-threatening or non-life-threatening like medication overuse.

?
How common is migraine, and who is most affected?

Migraine affects about 12% of the global population (roughly 45 million in the US) and disproportionately affects women three times more often than men, with about 18% of women experiencing it.

?
What are the distinct phases of a migraine attack?

A migraine can have four phases: a premonitory phase (calm before the storm), an aura phase (reversible neurological symptoms), the headache phase (pain and associated symptoms), and a postdrome phase (a 'hangover' feeling after the pain subsides).

?
Why is a headache diary so important for migraine diagnosis and treatment?

A detailed headache diary empowers patients and provides clinicians with crucial information about attack profiles, triggers, and symptom patterns over several months, guiding individualized treatment decisions for both acute and preventive therapies.

?
How does obesity impact migraine frequency?

Obesity is a significant risk factor for more frequent migraines; individuals who are morbidly obese are at five times higher risk, and those who are obese (BMI 30-35) are at twice the risk for more frequent attacks.

?
What are the key characteristics that distinguish a cluster headache?

Cluster headaches are extremely painful, often localized around one eye, peak quickly (5-15 minutes), last 15 minutes to 3 hours, and are accompanied by autonomic symptoms (e.g., droopy eyelid, tearing) and restlessness, disproportionately affecting men.

?
What is the role of CGRP in migraine, and how are CGRP antagonists used?

CGRP is a neuropeptide heavily involved in migraine pathophysiology, with elevated levels during attacks. CGRP antagonists (monoclonal antibodies and gepants) block CGRP or its receptor, significantly reducing migraine frequency and severity for many patients.

?
Are opioids recommended for acute migraine treatment?

Opioids are generally avoided for acute migraine treatment due to their high risk of leading to medication overuse headaches, which can increase the frequency and severity of migraines.

?
Do neuromodulation devices offer a viable treatment option for headaches?

Yes, external neuromodulation devices, which use magnetic or electrical stimulation to target the nervous system, are effective for both acute and preventive treatment of migraine, offering non-pharmacological alternatives.

?
When should someone be concerned about a headache and seek medical attention?

Seek medical attention for new onset headaches, changes in headache patterns, headaches with fever/rash/stiff neck, unintended weight loss, new headaches during pregnancy, headaches while immunosuppressed, new headaches after age 50, thunderclap headaches, or headaches provoked by cough/exertion/sexual activity/sleep, or with a positional component.

1. Maintain a Detailed Headache Diary

Keep a meticulous headache diary for several months to track headache patterns, triggers, symptoms, and treatment responses. This empowers patients and provides crucial data for clinicians to tailor effective treatment plans, especially for conditions like menstrual migraine.

2. Address Sleep Disturbances

Prioritize and address sleep disturbances like insomnia or sleep apnea, as they are significant risk factors for more frequent migraine attacks. Effective sleep management can improve overall headache control and treatment efficacy.

3. Avoid Medication Overuse Headaches

Be cautious with acute pain medications, especially opioids and barbiturate-containing analgesics. Using these more than a few times per month can paradoxically increase headache frequency and lead to medication overuse headaches.

4. Manage Stress and Mood

Employ stress reduction techniques like meditation, biofeedback, or cognitive behavioral therapy. Depression and anxiety are comorbid with migraine, and addressing these mood disorders can significantly improve headache frequency and severity.

5. Correct Obesity to Reduce Migraine Risk

If obese, pursue weight loss through surgical or non-surgical means. Morbid obesity increases the risk of frequent migraines by five times, and weight loss has been shown to improve migraine frequency and severity.

6. Adhere to Circadian Regularity

Maintain routine meal times, consistent sleep schedules, and regular caffeine intake (if applicable). Migraine sufferers are hypersensitive to changes, and regularity can help mitigate triggers like the ’letdown phenomenon’ on weekends.

7. Consider Preemptive Menstrual Migraine Treatment

For women with predictable menstrual migraines, discuss starting acute treatment a couple of days before the anticipated onset and continuing through the expected duration of the headache. This can prevent attacks before they become severe.

8. Seek Early Acute Migraine Treatment

Treat migraine attacks early, especially if experiencing allodynia (uncomfortable sensation to light touch). Waiting too long to use migraine-specific treatments like triptans can reduce their effectiveness.

9. Explore Neuromodulation Devices

Investigate external neuromodulation devices that stimulate nerves (e.g., trigeminal, vagus) or use remote electrical stimulation. These can be used for prevention or acute treatment, offering non-pharmacological options, especially for those seeking to avoid medications or during pregnancy.

10. Understand Migraine Prevention Goals

Recognize that preventive therapy aims to reduce frequency, intensity, and duration of attacks, improve acute treatment response, and reduce disease progression, not necessarily to cure migraine. It’s a long-term strategy that may take weeks to months to show full effect.

11. Avoid Naps for Cluster Headaches

Individuals with cluster headaches should avoid taking naps during the day. Naps can be a specific trigger for cluster attacks due to their involvement with the sleep-wake cycle.

12. Avoid Alcohol and Nitrates for Cluster Headaches

For cluster headache patients, avoid alcohol and foods containing nitrates. These substances can act as specific triggers for cluster attacks.

13. Know When to See a Doctor for Headaches

Consult a doctor for new onset headaches, changes in headache patterns, headaches with fever/rash/stiff neck, unintended weight loss, new headaches during pregnancy, headaches while immunosuppressed, new headaches after age 50, thunderclap headaches, or headaches provoked by cough/exertion/sexual activity/sleep, or with a positional component.

headache is one of the most common neurologic symptoms. Nearly at some point in every person's life, they're going to experience a headache.

Brian Grosberg

The international classification of headache disorders, kind of like the Bible of headache, but with no mention of God in it, breaks down primary and secondary headaches.

Brian Grosberg

migraine is not just a headache. There are phases that people experience.

Brian Grosberg

A lot of people with an invisible disease, I think back to a famous comedian, Rodney Dangerfield, that I don't get respect, I think that's migraine, right? Where most people think of it just as a headache without realizing it's a neurologic disease.

Brian Grosberg

Triggers are not the cause of the headache. Triggers are factors that will elicit a headache in somebody who's biologically predisposed.

Brian Grosberg

cluster headache is relatively uncommon, pretty rare relative to migraine and tension-type headache, but it's one of the most painful disorders known in the world.

Brian Grosberg

The idea of using prophylaxis or prevention is not to cure headache, is not to cure migraine, but to ultimately reduce the frequency, intensity, or duration of attacks.

Brian Grosberg

I often say that this is not Amazon Prime. I know we live in Amazon Prime society. You know, everybody's used to next day delivery, but often good things come to those who wait.

Brian Grosberg

PREEMPT Protocol for Botox in Chronic Migraine

Brian Grosberg
  1. Injections are given in the forehead.
  2. Injections are given on the sides of the head.
  3. Injections are given in the back of the head.
  4. Injections are given in the neck.
  5. Injections are given in the shoulders.
  6. Injections are administered quarterly.
1 billion
Migraine prevalence worldwide Roughly 45 million people in the United States.
12%
Migraine prevalence in the general population Disproportionately affects women.
18%
Migraine prevalence in women Three times more often than men.
Few hours
Proportion of neurologists specializing in headache Medical students and neurology residents receive very limited education on headaches.
50 or so
Number of fellowship-trained headache neurologists minted annually Insufficient for the demand of headache care.
1% to 2%
Prevalence of chronic migraine Patients experience 15 or more days of headache per month.
Two-thirds
Proportion of women experiencing perimenstrual migraine attacks With a nodal association around their menstrual period.
Less than 10%
Proportion of women with pure menstrual migraine Migraine occurs solely around menses.
About 50%
Proportion of women with menstrual-related migraine Migraine occurs around menses and at other times of the month.
Two-thirds to 70%
Proportion of migraine patients experiencing allodynia An uncomfortable sensation to normally non-uncomfortable stimuli.
30 to 60 minutes
Time for allodynia to kick in during a migraine After migraine onset, making triptans less effective if delayed.
5 times
Risk increase for frequent migraine with morbid obesity (BMI > 35) Compared to non-obese individuals.
2 times
Risk increase for frequent migraine with obesity (BMI 30-35) Compared to non-obese individuals.
40%
Proportion of migraine patients eligible for preventive therapy Based on medical indications, but only 16-17% actually receive it.
Roughly 28 days
Half-life of CGRP monoclonal antibodies Administered monthly or quarterly.
Up to 60%
Success rate of CGRP monoclonal antibodies Includes partial and complete responses in reducing migraine frequency/severity.
9 minutes
Time to pain relief for sumatriptan injection in cluster headache Median time for rapid onset relief.
47%
Migraine improvement during pregnancy (first trimester) Women notice improvement in migraine without aura.
80% to 87%
Migraine improvement during pregnancy (second/third trimester) Women notice improvement in migraine without aura.